Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - Growthpoint Properties Limited has completed the sale of its entire 14.2% stake in NewRiver REIT plc, according to a statement released Wednesday.
The transaction involved 67.4 million ordinary shares sold at 75 pence per share, generating gross proceeds of £50.5 million for Growthpoint. The sale represents Growthpoint’s complete exit from its investment in NewRiver REIT.
The placing received strong support from existing NewRiver shareholders and new investors, according to the press release. Panmure Liberum Limited acted as the sole bookrunner for the transaction.
Settlement of the placing is expected to occur on Friday, August 15, 2025, with Wednesday serving as the trade date.
NewRiver REIT will not receive any proceeds from this secondary share placement, as the transaction solely involved the sale of existing shares held by Growthpoint Properties.
The announcement was made through a regulatory filing as required under UK market regulations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.